A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
Not yet recruiting · NCT06970496 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 1 | 2026-08-14 | NCT06970496 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jiangxi Cancer Hospital | Nanchang | China | 18 |
| Ruijin Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 21 |
| Shanghai General Hospital | Shanghai | China | 35 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |
| The First Affiliated Hospital of Wenzhou Medical University | Wenzhou | China | 26 |
| Xijing Hospital | Xi'an | China | 6 |
| Zhujiang Hospital of Southern Medical University | Guangzhou | China | 7 |